What ages are Polivy’s clinical trial participants?
The provided information does not include Polivy trial eligibility or enrollment age breakdowns. Without the specific source (e.g., the trial protocol or Polivy’s prescribing information that lists study demographics), it isn’t possible to say age ranges or the age-wise distribution of participants.
Where to find the age breakdown (and what to look for)
If you’re trying to identify “age-wise who participated,” the relevant details are usually reported under study demographics in documents like:
- Polivy (polatuzumab vedotin) US prescribing information
- The clinical trial publication (usually a “Baseline characteristics” table)
- The trial registry entry (ClinicalTrials.gov) for age ranges and sometimes age group counts
Look for tables showing median age plus ranges, or explicit counts by age bands (for example, <65 vs. 65+).
If you share the trial or study name, I can answer more precisely
“Polivy” is studied across multiple trials and indications, and the participant ages can differ by study. If you tell me which one you mean (e.g., the trial name like ROMULUS/GO40775, a specific NCT number, or the cancer indication), I can narrow the answer to that study’s actual age breakdown.
Sources
No sources were provided with the question, so no citations can be included.